KCN1, a Novel Synthetic Sulfonamide Anticancer Agent: In Vitro and In Vivo Anti-Pancreatic Cancer Activities and Preclinical Pharmacology. This evidence concerns the gene KCNA10 and familial pancreatic carcinoma.